Assembly Biosciences Cash Flow Statement (2015-2025) | ASMB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-27.20M	-23.59M	-18.80M	-62.79M	-23.09M	-24.46M	-23.14M	-22.39M	-18.95M	-16.90M	-14.42M	-10.96M	-9.08M	-11.15M	-9.61M	-10.34M	-8.82M	-10.20M	-9.20M	22.09M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	-0.29M	1.99M	1.59M	1.95M	1.44M	1.58M	1.56M	2.01M	1.83M	1.19M	1.14M	0.96M	0.74M	0.83M	0.80M	0.75M	0.71M	0.83M	1.67M	1.46M
Deferred Taxes (Quarter)
Gains from Sales and Divestitures (Quarter)	0.14M	0.15M	0.18M	0.35M	0.09M	0.11M	0.23M	0.25M				0.04M				0.05M				0.02M
Gains from Investment Securities (Quarter)	7.38M	0.20M	1.86M	-3.06M	0.02M	0.73M	0.79M	-0.72M	-0.56M	-0.00M	0.22M	2.78M				1.97M		0.23M	0.23M	0.05M
Non-cash Items (Quarter)	4.26M	0.77M	0.59M	0.05M	0.01M	0.10M	0.00M					0.00M				1.38M				0.71M
Cash from Operations (Quarter)	-33.34M	-21.81M	-18.88M	-19.36M	-27.50M	-17.89M	-19.82M	-19.25M	-23.43M	-13.63M	-13.85M	73.65M	-18.36M	-17.10M	-15.24M	-0.41M	-23.44M	-16.76M	-15.13M	14.24M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.11M	0.12M	0.12M	0.12M	0.12M	0.12M	0.13M	0.12M	0.12M	0.13M	0.12M	0.08M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M
Change in Working Capital
Change in Receivables (Quarter)	-1.03M	0.09M	0.47M	-0.43M	0.19M	-0.00M	0.72M	-0.30M	-0.23M	-0.38M	-0.34M	0.04M		-0.04M					0.91M	0.06M
Change in Account Payables (Quarter)	-1.04M	-0.70M	-0.24M	0.03M	-1.25M	1.05M	-0.51M	0.55M	-1.27M	-0.32M	-0.15M	-0.30M	0.27M	0.07M	0.53M	-0.75M	0.29M	-0.13M	0.94M	-0.51M
Change in Accured Expenses (Quarter)	-0.10M	-7.55M	1.16M	5.45M	0.20M	0.85M	-2.23M	1.64M	-4.16M	1.03M	-0.30M	1.19M	1.17M	0.47M	-0.94M	0.42M	-4.56M	3.98M	-0.55M	1.25M
Other Working Capital Changes (Quarter)	-1.04M	0.01M	0.01M	5.14M	0.02M	-0.17M	-2.59M	1.42M	-0.92M	0.41M	-0.45M	-2.82M	0.65M	-14.97M	-6.84M	7.87M	-0.15M	-18.90M	-9.88M	28.17M
Investing Activities
Capital Expenditures (Quarter)	3.08M			0.02M			0.10M			0.05M	0.14M	0.07M	0.01M	0.01M					0.04M	0.02M
Sales of Property, Plant and Equipment (Quarter)	0.86M
Change in Acquisitions & Divestments (Quarter)	3.00M	95.95M	-86.45M		30.00M	16.50M	-19.50M	61.00M	10.00M	14.64M	21.67M	18.70M	21.00M	36.30M	39.20M	34.20M	26.43M	34.50M	22.70M	32.80M
Cash from Investing Activities (Quarter)	18.02M	-3.09M	20.07M	-8.48M	33.05M	9.60M	31.43M	16.56M	10.00M	-8.37M	18.88M	-89.65M	17.27M	5.11M	24.49M	-6.70M	6.59M	16.99M	-158.27M	21.22M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	34.14M	6.16M	10.05M	2.71M		0.18M		0.44M	4.49M	0.13M		9.19M		12.45M		17.00M	1.92M	0.36M	171.93M	0.46M
Additional items
Change in Cash (Quarter)	18.81M	-18.74M	11.24M	-25.13M	-5.55M	2.98M	11.61M	-2.25M	-8.94M	-21.86M	5.03M	-6.82M	-1.09M	0.46M	9.24M	9.89M	-14.93M	0.59M	-1.47M	35.92M
Free Cash Flow (Quarter)	-36.42M	-21.81M	-18.88M	-19.38M	-27.50M	-17.89M	-19.92M	-19.25M	-23.43M	-13.68M	-13.98M	73.58M	-18.38M	-17.12M	-15.24M	-0.41M	-23.44M	-16.76M	-15.18M	14.21M
Net Cash Flow (Quarter)	18.81M	-18.74M	11.24M	-25.13M	5.55M	-8.11M	11.61M	-2.25M	-8.94M	-21.86M	5.03M	-6.82M	-1.09M	0.46M	9.24M	9.89M	-14.93M	0.59M	-1.47M	35.92M

Research Tools

Assembly Biosciences Cash Flow Statement (2015-2025) | ASMB

Create an account

Sign In

Reset Password